Cognitive Impairment in Pediatric ALL Survivors Even Without Brain RT
Even in the absence of cranial radiation therapy, survivors of childhood acute lymphoblastic leukemia (ALL) have decreased neurocognitive...
Jun 9, 2015
Study explains how early childhood vaccination reduces leukemia risk
A team led by UCSF researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia (ALL),...
May 20, 2015
Researchers report success in mitigating treatment-related side effects in childhood leukemia
A team of researchers from the University of Delaware, Nemours/A.I. duPont Hospital for Children and Jeffersn Medical College has...
May 8, 2015
CAR T-Cell Therapy Surpasses 90% Complete Remission Rate in Pediatric ALL
The chimeric antigen receptor (CAR) T-cell therapy JCAR017 elicited a 91% complete remission rate in pediatric patients with...
Apr 29, 2015
Genetic Variant Linked to Nerve-related Side Effects from Childhood ALL Treatment
A genome-wide association study published today in the Journal of the American Medical Association describes a regulatory variant that...
Feb 24, 2015
Higher Birthweight Linked to Increased Childhood Cancer Risk
Studies exploring potential prenatal risk factors for childhood leukaemia have consistently found that children with the disease have...
Feb 3, 2015
Predominant Cancer in Children Gets Potential New Drug Therapy
Scientists at the Children’s Hospital Los Angles (CHLA) have developed a new and much needed treatment to combat drug resistance in the...
Jan 27, 2015
Benefits persist in T cell therapy for children with relapsed leukemia
An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising...
Dec 8, 2014
Racial, Demographic Disparities Exist in Follow-Up Care for Childhood Cancer Survivors
Hispanic childhood cancer survivors are less likely to receive follow-up care later in life than white survivors, according to a new...
Nov 13, 2014
New study demonstrates advances in creating treatment for common childhood blood cancer
Researchers at NYU Langone Medical Center conclude new drug in development may offer first alternative to standard chemotherapy for...
Oct 20, 2014